Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Mulder

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Folia Biologica|June 5, 2003
A prospective open-label single-arm phase II study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patientsZ Varga, P de Mulder, W Kruit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Water Research|August 6, 2018
High-resolution mapping and modeling of anammox recovery from recurrent oxygen exposureD Seuntjens, J M Carvajal-Arroyo, M Ruopp, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)C M L van Herpen, L D Locati, J Buter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepamD Cunningham, M Dicato, J Verweij, et al.
British Journal of Cancer|March 5, 2004
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility studyD Schrijvers, C Van Herpen, J Kerger, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2005
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumoursC N Sternberg, P de Mulder, J H Schornagel, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Folia Biologica|June 5, 2003
A prospective open-label single-arm phase II study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patientsZ Varga, P de Mulder, W Kruit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Water Research|August 6, 2018
High-resolution mapping and modeling of anammox recovery from recurrent oxygen exposureD Seuntjens, J M Carvajal-Arroyo, M Ruopp, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)C M L van Herpen, L D Locati, J Buter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepamD Cunningham, M Dicato, J Verweij, et al.
British Journal of Cancer|March 5, 2004
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility studyD Schrijvers, C Van Herpen, J Kerger, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2005
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumoursC N Sternberg, P de Mulder, J H Schornagel, et al.
Pageof 2